FDA Extends Approval for Alirocumab to Lower LDL-C in Pediatric Patients with HeFHÂ
Addressing an Unmet Need in Pediatric Patients with HeFH Heterozygous familial hypercholesterolemia (HeFH) affects about 1 in 313 people—characterized by dangerously high low-density lipoprotein cholesterol (LDL-C) levels. Untreated, it can trigger early heart disease. Detecting and treating it early in pediatric patients can prevent heart problems later. American College of Cardiology/American Heart Association guidelines define acceptable LDL-C […]
FDA Expands Labels for Bempedoic Acid Tablets and Combination Bempedoic Acid and Ezetimibe Tablets to Reduce Cardiovascular RiskÂ
Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heart disease remains the leading cause of death for men and women. 80% of heart attacks and strokes linked to CVD are preventable with optimal risk factor management. However, every 40 seconds, an individual […]
Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week
In today’s society, the prevalence of obesity has become a significant concern. With sedentary lifestyles and the easy availability of unhealthy food choices, more and more individuals are struggling with weight-related issues. This has led to a growing recognition of the importance of maintaining a healthy weight and taking proactive steps towards achieving it. Currently, […]
ACC/AHA Release Updated 2023 Guidelines for Atrial Fibrillation
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrial fibrillation (AF). These new guidelines provide necessary updates to both the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation and the 2019 AHA/ACC/HRS Focused Update of the […]
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and […]
Depression Linked to Chronic Disease in Women
Recent statistics reveal the jarring prevalence of depression among U.S. adults with an estimated 17.3 million affected American adults, or over 7% of the population. Although depression is a serious condition on its own, a growing body of research suggests it has a connection to a host of cardiometabolic conditions. While the comorbidity of depression […]
Could Exercise Counter a Sedentary Lifestyle?
On average, Americans currently spend around 11 hours a day sitting and research suggests that only about 20% of adults are meeting physical activity guidelines. The trend toward increasingly sedentary lifestyles is becoming a significant public health issue, resulting in an estimated $24 billion in direct medical spending. Research has long shown that a sedentary lifestyle […]
CV Mortality Rates Among Asian-American Subgroups
To date, the majority of data on Asian-American cardiometabolic health is aggregated into the wide-ranging Asian subgroup and does not delineate the differences between specific subgroup populations – some of which are at a much higher risk of CVD than others. A new study aims to identify the specific risks targeting Asian-American subgroup populations by examining […]
Plant-Based Diets for Lowering CV Mortality Risk
The anti-inflammatory and antioxidant effects of vegetable-focused diets are well-known, however, recent research reveals that the quality of plant foods is just as important as their quantity. Not all plant-based diets are equal and those centered around high-quality, healthy plant foods have been proven to greatly surpass plant-based diets with less-healthy foods which can ultimately […]
5 Cardiometabolic Health Topics You Can’t Miss at CMHC West 2019
With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing […]
